ReviewTranslational andrology and urology2025
Silymarin as a promising antioxidant for sperm cryopreservation: a narrative review.
Review in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Sperm cryopreservation is a key technology in preserving male fertility, particularly for patients undergoing chemotherapy, radiotherapy, or those with compromised semen quality. However, the cryopreservation and thawing processes frequently lead to oxidative stress, resulting in significant deterioration of sperm motility, viability, morphology, and DNA integrity. This review explores the potential role of plant-derived antioxidants in mitigating cryodamage, focusing on silymarin-a polyphenolic flavonoid extracted from Silybum marianum. The objective is to evaluate the effect of silymarin on post-thaw sperm parameters in comparison to traditional antioxidants such as vitamin C and vitamin E. Methods: This narrative review was conducted by systematically searching PubMed, Scopus, Web of Science, and ScienceDirect for publications between 2015 and 2025. Relevant studies examining the influence of silymarin and other antioxidants on sperm cryopreservation outcomes were identified and analyzed. Emphasis was placed on experimental models that assessed motility, viability, morphology, DNA fragmentation, and reactive oxygen species (ROS) levels. Key Content and Findings: Findings suggest that all three antioxidants demonstrate potential in enhancing post-thaw sperm quality. However, silymarin consistently exhibited superior effects on sperm motility, membrane integrity, and antioxidant defense, particularly when used at optimized concentrations. Despite these promising results, clinical protocols for silymarin remain undeveloped. Conclusions: Silymarin shows promise as a multifunctional antioxidant for improving post-cryopreservation sperm quality. Its incorporation into assisted reproductive technology (ART) protocols may enhance reproductive outcomes. Further clinical research is needed to validate its efficacy and determine optimal dosing for human applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.